Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.52B | 14.19B | 14.27B | 14.00B | 15.48B | 35.71B | Gross Profit |
6.26B | 6.17B | 6.70B | 6.28B | 6.95B | 8.16B | EBIT |
-1.10B | -1.03B | 161.19M | 644.85M | 1.24B | 2.13B | EBITDA |
-938.68M | -57.72M | 1.89B | 1.02B | 539.39M | 2.13B | Net Income Common Stockholders |
-666.76M | -530.40M | 1.01B | 254.88M | 310.44M | 1.43B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
10.59B | 10.10B | 12.86B | 14.31B | 13.77B | 17.97B | Total Assets |
31.03B | 29.53B | 27.08B | 25.41B | 25.09B | 27.07B | Total Debt |
14.92B | 17.11B | 11.66B | 9.47B | 10.26B | 11.55B | Net Debt |
4.33B | 7.01B | -1.20B | -4.84B | -3.51B | -3.51B | Total Liabilities |
21.27B | 20.20B | 16.28B | 15.44B | 15.44B | 17.33B | Stockholders Equity |
9.62B | 9.20B | 10.66B | 9.80B | 9.39B | 9.21B |
Cash Flow | Free Cash Flow | ||||
0.00 | -1.20B | -424.17M | 1.56B | 38.14M | 2.31B | Operating Cash Flow |
0.00 | -1.14B | -385.00M | 1.59B | 683.15M | 2.43B | Investing Cash Flow |
0.00 | -6.59B | -1.64B | -708.65M | -1.28B | 72.71M | Financing Cash Flow |
0.00 | 4.63B | 572.01M | -345.60M | -692.96M | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥5.97B | 22.71 | ― | 29.19% | ― | ||
76 Outperform | ¥5.93B | 50.49 | ― | 14.82% | 191.31% | ||
75 Outperform | ¥7.25B | 44.15 | ― | 13.76% | -15.36% | ||
62 Neutral | $11.92B | 10.03 | -7.37% | 3.70% | 7.32% | -8.25% | |
58 Neutral | ¥5.05B | 48.27 | ― | 51.83% | -62.04% | ||
51 Neutral | ¥7.21B | ― | 3.94% | -15.71% | 65.07% | ||
49 Neutral | ¥7.00B | ― | ― | -0.55% | -159.25% |